KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palvella Therapeutics, Inc. (PVLA) Total Current Liabilities (2016 - 2022)

Palvella Therapeutics (PVLA) has disclosed Total Current Liabilities for 12 consecutive years, with $4.3 million as the latest value for Q3 2024.

  • On a quarterly basis, Total Current Liabilities fell 85.26% to $4.3 million in Q3 2024 year-over-year; TTM through Sep 2024 was $4.3 million, a 85.26% decrease, with the full-year FY2023 number at $2.4 million, down 93.55% from a year prior.
  • Total Current Liabilities was $4.3 million for Q3 2024 at Palvella Therapeutics, down from $6.3 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $50.6 million in Q4 2021 to a low of $2.4 million in Q4 2023.
  • A 5-year average of $27.7 million and a median of $30.3 million in 2021 define the central range for Total Current Liabilities.
  • Peak YoY movement for Total Current Liabilities: surged 152.43% in 2021, then tumbled 93.55% in 2023.
  • Palvella Therapeutics' Total Current Liabilities stood at $22.1 million in 2020, then surged by 128.32% to $50.6 million in 2021, then dropped by 27.65% to $36.6 million in 2022, then crashed by 93.55% to $2.4 million in 2023, then soared by 80.25% to $4.3 million in 2024.
  • Per Business Quant, the three most recent readings for PVLA's Total Current Liabilities are $4.3 million (Q3 2024), $6.3 million (Q2 2024), and $7.5 million (Q1 2024).